Emergence of mixed infection of Beijing/Non-Beijing strains among multi-drug resistant Mycobacterium tuberculosis in Pakistan

3 Biotech

Volumn 6, Issue 1, 2016, Pages

  Mustafa, Samar ^a   Javed, Hasnain ^a,b   Hashmi, Jawairia ^a   Jamil, Nazia ^a   Tahir, Zarfishan ^b   Akhtar, Abdul Majeed ^b  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b Institute of Public Health (IPH)   (Pakistan)

Author keywords

Beijing; CRISPR; IS6110; Mycobacterium tuberculosis; Non Beijing; Resistance; Transposase

Indexed keywords

ETHAMBUTOL; IS6110; ISONIAZID; MOLECULAR MARKER; RIFAMPICIN; STREPTOMYCIN; TRANSPOSASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DNA ISOLATION; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; FEMALE; GEL ELECTROPHORESIS; GENOTYPE; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; PAKISTAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPUTUM ANALYSIS;

EID: 84992311388     PISSN: 2190572X     EISSN: 21905738     Source Type: Journal    
DOI: 10.1007/s13205-016-0423-9     Document Type: Article

References (37)

1. Amaro A, Duarte E, Amado A, Ferronha H, Botelho A (2008) Comparison of three DNA extraction methods for Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium subsp. avium. Lett Appl Microbiol 47:8–11
2. Arif HM, Hussain Z (2014) Prevalence of Mycobacterium tuberculosis Beijing strains in Punjab Pakistan. Int J Curr Res Aca Rev 2:74–82
3. Balamurugan R, Venkataraman S, John K, Ramakrishna BS (2006) PCR amplification of the IS6110 insertion element of Mycobacterium tuberculosis in fecal samples from patients with intestinal tuberculosis. J Clin Microbiol 44:1884–1886
4. Becerra M, Freeman J, Bayona J, Shin S, Kim J, Furin J, Werner B, Sloutsky A, Timperi R, Wilson M (2000) Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 4:108–114
5. Canetti G, Fox W, Aa Khomenko, Mahler H, Menon N, Mitchison D, Rist N, Šmelev N (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 41:21
6. Cappuccino JG, Sherman N (2014) Microbiology: a laboratory manual. Pearson, London
7. Cohen T, Colijn C, Finklea B, Murray M (2007) Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J R Soc Interface 4:523–531
8. Cohen T, van Helden PD, Wilson D, Colijn C, McLaughlin MM, Abubakar I, Warren RM (2012) Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev 25:708–719
9. Doroudchi M, Kremer K, Basiri EA, Kadivar MR, Van Soolingen D, Ghaderi AA (2000) IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scand J Infect Dis 32:663–668
10. Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D (2012) Diagnosis of tuberculosis and drug resistance: what can new tools bring us? (State of the art series. New tools. Number 1 in the series). Int J Tuberc Lung Dis 16:860–870
11. Du Plessis D, Warren R, Richardson M, Joubert J, Van Helden P (2001) Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting. Tuberculosis 81:211–220
12. Filliol I, Driscoll JR, Van Soolingen D, Kreiswirth BN, Kremer K, Valétudie G, Anh DD, Barlow R, Banerjee D, Bifani PJ (2002) Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis 8:1347–1349
13. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8:843–849
14. Hamilton CD, Sterling TR, Blumberg HM, Leonard M, McAuley J, Schlossberg D, Stout J, Huitt G (2007) Extensively drug-resistant tuberculosis: are we learning from history or repeating it? Clin Infect Dis 45:338–342
15. Hasan Z, Tanveer M, Kanji A, Hasan Q, Ghebremichael S, Hasan R (2006) Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals predominance of Central Asian Strain 1 and Beijing isolates. J Clin Microbiol 44:1763–1768
16. Huang H-Y, Tsai Y-S, Lee J-J, Chiang M-C, Chen Y-H, Chiang C-Y, Lin N-T, Tsai P-J (2010) Mixed infection with Beijing and non-Beijing strains and drug resistance pattern of Mycobacterium tuberculosis. J Clin Microbiol 48:4474–4480
17. Johnson R, Warren R, Van Der Spuy G, Gey van Pittius N, Theron D, Streicher E, Bosman M, Coetzee G, Van Helden P, Victor T (2010) Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain (Short communication). Int J Tuberc Lung Dis 14:119–121
18. Kaul KL (2001) Molecular detection of Mycobacterium tuberculosis: impact on patient care. Clin Chem 47:1553–1558
19. Kent P, Kubica G (1985) Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control, Atlanta
20. Khosravi AD, Goodarzi H, Alavi SM, Akhond MR (2014) Application of deletion-targeted multiplex PCR technique for detection of Mycobacterium tuberculosis Beijing strains in samples from tuberculosis patients. Iran J Microbiol 6:330
21. Lange C, Abubakar I, Alffenaar J-WC, Bothamley G, Caminero JA, Carvalho ACC, Chang K-C, Codecasa L, Correia A, Crudu V (2014) Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J 44:23–63
22. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M (2009) Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 68:2240–2246
23. Menéndez MC, Jiménez MS, Yubero J, García MJ (2014) Mycobacterium kumamotonense, another member of the Mycobacterium terrae complex unusually carrying two copies of the ribosomal RNA operon. Mycobact Dis 4:176. doi:10.4172/2161-1068.1000176
24. Narasimhan P, Wood J, MacIntyre CR, Mathai D (2013) Risk factors for tuberculosis. Pulm Med 2013:1–11
25. Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang Y-W (2010) Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J Clin Microbiol 48:3544–3550
26. Programme NTC (2012) Annual report 2012: National TB Control Programme. NTP
27. Siddiqui RT, Akhtar MW, Qureshi JA (2013) The presence and copy number of insertion sequence IS6110 in Mycobacterium tuberculosis isolates from Pakistan. Int J Agric Biol 15:607–611
28. Soini H, Musser JM (2001) Molecular diagnosis of mycobacteria. Clin Chem 47:809–814
29. Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, Ghebremicheal S, Hasan R (2008) Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis 8:171
30. Thomsen V, Bauer J, Lillebaek T, Glismann S (2000) Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark. Eur Respir J 16:203–208
31. Thorne N, Borrell S, Evans J, Magee J, de Viedma DG, Bishop C, Gonzalez-Martin J, Gharbia S, Arnold C (2011) IS6110-based global phylogeny of Mycobacterium tuberculosis. Infect Genet Evol 11:132–138
32. Tripathi K, Tripathi PC, Nema S, Shrivastava AK, Dwiwedi K, Dhanvijay AK (2014) Modified Petroff’s method: an excellent simplified decontamination technique in comparison with Petroff’s method. IJRTSAT 10:461–464
33. Van Embden J, Cave MD, Crawford JT, Dale J, Eisenach K, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick T (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31:406–409
34. Wang X, Liu H, Wei J, Wu X, Yu Q, Zhao X, Lyu J, Lou Y, Wan K (2015) An investigation on the population structure of mixed infections of Mycobacterium tuberculosis in Inner Mongolia, China. Tuberculosis 95(6):695–700
35. WHO (2015) Global Tuberculosis report 2015. World Health Organization
36. Zetola NM, Shin SS, Tumedi KA, Moeti K, Ncube R, Nicol M, Collman RG, Klausner JD, Modongo C (2014) Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol 52:2422–2429
37. Zheng C, Li S, Luo Z, Pi R, Sun H, He Q, Tang K, Luo M, Li Y, Couvin D, Rastogi N, Sun Q (2015) Mixed infections and rifampin heteroresistance among Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 53(7):2138–2147